Industry Spotlight on Aerie
‘Targeting the diseased tissue to restore normal function is a fundamental tenet of medicine, yet no available glaucoma therapies do this. We founded Aerie with the specific goal of bringing a safe and effective trabecular outflow drug to physicians and their patients.’1 -Dr. David Epstein (1943-2014) Former Duke University Chairman of the Department of Ophthalmology […]